Ann Lee is Senior Vice President at Genentech and Head of Global Technical Development at Roche. She is responsible for developing process and analytical technologies, scaling-up, manufacturing, control and delivering GMP clinical supplies for all products in the pipeline. Prior to joining Genentech in September 2005, Ann worked for 16 years at Merck & Co., Inc., where she held several leadership positions in vaccine development in the Merck Research Laboratories. She was project leader for a number of vaccines including PedvaxHIB, COMVAX, 2nd generation PNEUMOVAX23, and GARDASIL. She also served as Vice President, Chemical Technology and Engineering in the manufacturing division. Ann holds a Bachelor of Science in Chemical Engineering from Cornell University, and a PhD from Yale University. She is a member of the National Academy of Engineering, American Institute of Chemical Engineers, American Chemical Society, Society of Women Engineers, Sigma Xi, a Fellow of the American Institute of Medical and Biological Engineering, and serves on various academic and scientific advisory boards. She has been Associate Editor of Biotechnology and Applied Biochemistry, organizer of numerous conferences and an invited lecturer at various meetings and universities. Ann is actively involved in company-wide recruiting efforts and mentoring boys and girls in science.